Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TNFRSF11B is a member of the TNF-receptor superfamily. Additionally we are shipping Tumor Necrosis Factor Receptor Superfamily, Member 11b Kits (66) and Tumor Necrosis Factor Receptor Superfamily, Member 11b Proteins (30) and many more products for this protein.
Showing 10 out of 120 products:
Human Monoclonal TNFRSF11B Primary Antibody for WB - ABIN108499
Simonet, Lacey, Dunstan, Kelley, Chang, Lüthy, Nguyen, Wooden, Bennett, Boone, Shimamoto, DeRose, Elliott, Colombero, Tan, Trail, Sullivan, Davy, Bucay, Renshaw-Gegg, Hughes, Hill, Pattison, Campbell et al.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. ... in Cell 1997
Show all 5 references for ABIN108499
Human Monoclonal TNFRSF11B Primary Antibody for EIA, WB - ABIN114693
Bolten, Weissbach, Kaden: [Cryopreserved human sperm deposits: usability after decades of storage] in Der Urologe. Ausg. A 2005
Show all 3 references for ABIN114693
Human Monoclonal TNFRSF11B Primary Antibody for EIA, WB - ABIN114706
Yasuda, Shima, Nakagawa, Mochizuki, Yano, Fujise, Sato, Goto, Yamaguchi, Kuriyama, Kanno, Murakami, Tsuda, Morinaga, Higashio: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. in Endocrinology 1998
Show all 3 references for ABIN114706
Human Monoclonal TNFRSF11B Primary Antibody for EIA, FACS - ABIN1108534
Golledge, Biros, Clancy, Cooper, Palmer, Norman: A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. in American journal of hypertension 2009
Show all 2 references for ABIN1108534
Human Monoclonal TNFRSF11B Primary Antibody for EIA, IHC (p) - ABIN1108535
Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ... in American journal of human genetics 2009
Show all 2 references for ABIN1108535
Cow (Bovine) Polyclonal TNFRSF11B Primary Antibody for IHC, ELISA - ABIN1582232
Fradet, Sorel, Bouazza, Goehrig, Dépalle, Bellahcène, Castronovo, Follet, Descotes, Aubin, Clézardin, Bonnelye: Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. in Cancer research 2011
Show all 2 references for ABIN1582232
In lung cancer, serum OPG levels in the BM and BM- groups were significantly increased compared with healthy controls.
Alendronate stimulated OPG mRNA and protein expression, but not RANKL (show TNFSF11 Antibodies) expression, in fibroblasts from patients with aseptic loosening following total hip arthroplasty.
Single nucleotide polymorphisms (SNPs) rs1035798 in RAGE (show AGER Antibodies) gene, rs2073617 and rs2073618 in TNFRSF11B, and rs3732410 in Golgb1 (show GOLGB1 Antibodies) will be investigated on whether there is an association with hemorrhagic stroke (HS) in Chinese population.
Hypoxia can affect the expression of RANKL (show TNFSF11 Antibodies) and OPG in human periodontal ligament cells
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-kappaB Ligand (RANKL (show TNFSF11 Antibodies)), is Dysregulated in BRCA Mutation Carriers
expression of OPG, RANK and RANKL (show TNFSF11 Antibodies) genes exert a crucial role in the progression of avascular necrosis
Studies demonstrate that OPG induces proliferation, angiogenesis, aneuploidy and survival through manipulation of various survival and aneuploidy related kinases in human mammary epithelial cells spheres.
Germline variation in TNFRSF11B gene is associated with the risk of multiple myeloma bone disease.
the independent and positive (beta = 0.449, p = 0.004, and R(2) = 0.185) association between the OxS marker and RANKL/OPG (show TNFSF11 Antibodies) ratio which was found in osteopenic but not in the other 2 sample groups.
the rs3134069 polymorphism of TNFRSF11B seems to be the most likely protective genetic factor in chronic kidney disease development in patients with type 2 diabetes mellitus and diabetic foot
The OPG (show TNFSF11 Antibodies) expression levels decreased while those of RANKL (show TNFSF11 Antibodies) and RUNX2 (show RUNX2 Antibodies) increased during orthodontic tooth movement, which suggested that they play a role in the osteogenesis process and the reconstruction of periodontal tissue.
Low-frequency vibration may promote the osteogenic differentiation capability of BMSC probably through regulating the OPG/RANKL (show TNFSF11 Antibodies) mRNA expression.
Regional variation of periosteal activity at the mandibular ramus is regulated by differential expression of osteoprotegerin.
OPG (show TNFSF11 Antibodies) expression in chondrocyte increases bone mass in the proximal metaphysis of tibiae through negative regulation of osteoclast formation.
the generation of Rag2GFP+ regulatory T cells is unaltered in Tnfrsf11b(-/-) mice
identify osteoprotegerin as a HIF target gene capable of directing osteoblast-mediated osteoclastogenesis to regulate bone homeostasis
Osteoprotegerin is increased in metabolic syndrome and promotes adipose tissue proinflammatory changes.
Osteoprotegerin inhibits vascular calcification by regulating the procalcific effects of RANKL (show TNFSF11 Antibodies) and Il6 (show IL6 Antibodies) on vascular smooth muscle cells.
These results indicate that OPG (show TNFSF11 Antibodies) derived either from the bone marrow or from the vessel wall is sufficient to slow down lesion progression and vascular calcification independent of bone turnover.
High concentrations of alendronate decrease the expressions of OPG (show TNFSF11 Antibodies) and RANKL (show TNFSF11 Antibodies) in cultured osteoblasts.
In a xenograft model, increased osteoprotegerin expression correlated with a delay to pathologic fracture suggesting a potential role for mTOR (show FRAP1 Antibodies) inhibitors in the treatment of neuroblastoma (show ARHGEF16 Antibodies) bone metastases.
Data indicate in TLR4 (show TLR4 Antibodies)(-/-) mice, higher expression levels of IL-1beta (show IL1B Antibodies) and lower expression levels of VEGF (show VEGFA Antibodies), RANK, RANKL (show TNFSF11 Antibodies) and OPG (show TNFSF11 Antibodies) were detected at late time points (> postoperative 4 days).
Coptisine inhibits RANKL (show TNFSF11 Antibodies)-induced NF-kappaB (show NFKB1 Antibodies) phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL (show TNFSF11 Antibodies) and OPG (show TNFSF11 Antibodies) gene expression in osteoblastic cells.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is an osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption. This protein specifically binds to its ligand, osteoprotegerin ligand, both of which are key extracellular regulators of osteoclast development. Studies of the mouse counterpart also suggest that this protein and its ligand play a role in lymph-node organogenesis and vascular calcification. Alternatively spliced transcript variants of this gene have been reported, but their full length nature has not been determined.
, tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
, tumor necrosis factor receptor superfamily, member 11b
, tumor necrosis factor receptor superfamily member 11B-like
, osteoclastogenesis inhibitory factor
, tumor necrosis factor receptor superfamily member 11B